Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Longevity / Senolytic StackEvidence Grade: C (FOXO4-DRI) / B (Epithalon)
FOXO4-DRI + Epithalon Stack Protocol Guide
The FOXO4-DRI + Epithalon stack is an advanced longevity protocol combining senolytic therapy with telomere preservation. FOXO4-DRI selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction that keeps zombie cells alive. Senescent cells accumulate with age, secreting inflammatory SASP factors that damage surrounding tissue. Epithalon activates telomerase to protect telomere length in healthy cells. The synergy: FOXO4-DRI clears damaged senescent cells while epithalon ensures remaining healthy cells maintain replicative capacity. This is experimental due to limited FOXO4-DRI human data.
FOXO4-DRI is a D-retro-inverso peptide that disrupts the FOXO4-p53 interaction in senescent cells. Normally, FOXO4 sequesters p53 in the nucleus of senescent cells, preventing apoptosis. FOXO4-DRI competitively disrupts this binding, releasing p53 to trigger programmed cell death specifically in senescent cells while leaving healthy cells unaffected.
Epithalon Synergy
After clearing senescent cells with FOXO4-DRI, the remaining healthy cell population benefits from epithalon telomerase activation. This preserves their replicative capacity, preventing them from entering senescence prematurely. The sequential approach - clear the damaged, protect the healthy - addresses aging from both the damage accumulation and prevention angles.
Combined Dosing Protocol
Protocol
Compound 1
Compound 2
Timing
Duration
Standard
FOXO4-DRI 5mg/kg x 3 days
Epithalon 5mg/day x 10 days
Quarterly + biannual
3 + 10 days/cycle
Conservative
FOXO4-DRI 3mg/kg x 3 days
Epithalon 5mg/day x 10 days
Quarterly + biannual
3 + 10 days
Sequential
FOXO4-DRI 5mg/kg x 3 days, then Epi day 7
Epithalon 10mg/day x 10 days
Sequential
~2 weeks combined
Reconstitution & Preparation
FOXO4-DRI Preparation
FOXO4-DRI: lyophilized vials (varies by source)
Reconstitute with sterile or BAC water
Dose calculated by body weight (mg/kg)
SubQ or slow IV administration
Epithalon Preparation
Epithalon: 10mg or 50mg vials lyophilized
10mg vial + 2mL BAC water = 5mg/mL
5mg dose = 100 units
Refrigerate, use within 14 days
Stacking Schedule (AM/PM Timing)
FOXO4-DRI Cycle (3 Days)
Days 1-3: FOXO4-DRI 3-5mg/kg SubQ once daily
AM dosing preferred
Stay well hydrated (cell clearance produces debris)
Rest recommended on treatment days
Epithalon Cycle (10 Days)
Days 1-10: Epithalon 5-10mg SubQ daily, AM
Begin 4-7 days after FOXO4-DRI cycle
Sequential: clear senescent cells first, then protect healthy
Repeat FOXO4-DRI quarterly, epithalon biannually
Expected Timeline
Days 1-3
FOXO4-DRI targets senescent cells. Possible flu-like symptoms as cells undergo apoptosis. Rest and hydrate.
Days 4-7
Body clears senescent cell debris. Transient inflammation then resolution. Begin epithalon day 7.
Days 7-17
Epithalon activates telomerase in healthy cells. Pineal function normalizing. Sleep improving.
SASP markers (IL-6, TNF-alpha) should decrease after FOXO4-DRI as senescent cell burden reduces. Telomere length tracks epithalon effects over 6-12 months. Liver/kidney function must be monitored.
